Status:

COMPLETED

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

Lead Sponsor:

Deutsches Herzzentrum Muenchen

Conditions:

Myocardial Infarction

Eligibility:

FEMALE

18+ years

Brief Summary

The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.

Eligibility Criteria

Inclusion

  • acute myocardial infarction; female gender

Exclusion

  • \-

Key Trial Info

Start Date :

January 1 1995

Trial Type :

OBSERVATIONAL

End Date :

Estimated Enrollment :

750 Patients enrolled

Trial Details

Trial ID

NCT00196287

Start Date

January 1 1995

Last Update

March 12 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Deutsches Herzzentrum Muenchen

Munich, Germany, 80636

2

1. Medizinische Klinik, Klinikum rechts der Isar

Munich, Germany, 81675

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients | DecenTrialz